CHAIN 1 197 Cyclin-dependent kinase inhibitor 1B.
/FTId=PRO_0000190085.
MOTIF 153 169 Nuclear localization signal (Potential).
SITE 90 90 Required for interaction with NUP50.
MOD_RES 10 10 Phosphoserine; by UHMK1.
MOD_RES 74 74 Phosphotyrosine; by SRC (By similarity).
MOD_RES 88 88 Phosphotyrosine; by ABL, LYN, SRC and
JAK2 (By similarity).
MOD_RES 89 89 Phosphotyrosine (By similarity).
MOD_RES 187 187 Phosphothreonine; by PKB/AKT1 and CDK2.
MOD_RES 197 197 Phosphothreonine; by PKB/AKT1, RPS6KA1,
RPS6KA3 and PIM1 (By similarity).
MUTAGEN 10 10 S->A: Loss of phosphorylation in G(0)
phase. No change in cMYC-induced CDK2-
mediated phosphorylation. Rapid
dissociation from the cyclin E/CDK2
complex after induction by cMYC. Loss of
protein stability in G(0) phase. No
change in protein stability at S-phase.
MUTAGEN 90 90 R->G: Loss of interaction with NUP50. No
cyclin E-mediated degradation of
phosphorylated p27KIP1.
MUTAGEN 187 187 T->E: Loss of cMyc-induced CDK2-mediated
phosphorylation. Rapid dissociation from
the cyclin E/CDK2 complex after induction
by c-Myc.
MUTAGEN 187 187 T->V: Loss of cMYC-induced CDK2-mediated
phosphorylation Dissociates very slowly
from the cyclin E/CDK2 complex after
induction by cMYC. Cell cycle arrest.
CONFLICT 22 22 E -> D (in Ref. 1; AAA21149, 2; AAA20235
and 5; AAH14296).
CONFLICT 141 141 P -> Q (in Ref. 1; AAA21149, 2; AAA20235
and 5; AAH14296).
Back to Top